AnPac Bio-Medical Science: Sunil Pandit

AnPac Bio-Medical Science has hired Sunil Pandit as its US CEO. Pandit will lead AnPac Bio’s US R&D and commercialization efforts for its cancer differentiation analysis technology applied to cancer screening and early detection. He is a licensed CLIA-laboratory director and will continue to serve in that capacity for the firm's laboratory in Springhouse, Pennsylvania. Pandit previously held positions at diagnostics and pharmaceutical companies, including Janssen Diagnostics; Siemens Healthcare Diagnostics, now Siemens Healthineers; National Institutes of Health; and GlaxoSmithKline.